Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Liver Neoplasms, Experimental × carotuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Liver Neoplasms, Experimental 1 Liver Neoplasms 1 Hemangiosarcoma 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Astrocytoma 1 Adenoma, Liver Cell 1

Interventions

carotuximab 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01306058 2019-01-23

Sorafenib and TRC105 in Hepatocellular Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed

27 enrolled 32 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Liver Neoplasms, Experimental, Adenoma, Liver Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡